Talphera, Inc. (TLPH): Total Liabilities
$12.68M
As of 2025-12-31
$12.40M
As of 2026-06-30
-20.9%
3-year compound annual growth
-36.4%
5-year compound annual growth
-18.2%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.68M | +23.9% | 2026-03-23, Balance as of period end |
| 2024-12-31 | $10.23M | +62.7% | 2026-03-23, Balance as of period end |
| 2023-12-31 | $6.29M | -75.5% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $25.67M | -77.4% | 2024-03-06, Balance as of period end |
| 2021-12-31 | $113.79M | -6.8% | 2023-03-31, Balance as of period end |
| 2020-12-31 | $122.05M | -8.1% | 2022-03-10, Balance as of period end |
| 2019-12-31 | $132.77M | +14.2% | 2021-03-15, Balance as of period end |
| 2018-12-31 | $116.28M | +3.8% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $112.06M | +6.4% | 2019-03-07, Balance as of period end |
| 2016-12-31 | $105.33M | +11.3% | 2018-03-09, Balance as of period end |
| 2015-12-31 | $94.67M | +138.1% | 2017-03-03, Balance as of period end |
| 2014-12-31 | $39.76M | +7.8% | 2016-03-07, Balance as of period end |
| 2013-12-31 | $36.87M | +20.2% | 2015-03-13, Balance as of period end |
| 2012-12-31 | $30.67M | +31.3% | 2014-03-17, Balance as of period end |
| 2011-12-31 | $23.37M | +39.2% | 2013-03-12, Balance as of period end |
| 2010-12-31 | $16.78M | n/a | 2012-03-23, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Talphera, Inc. (TLPH) | 2025-12-31 | $12.68M | +23.9% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $1.85M | -85.8% |
| Jupiter Neurosciences, Inc. (JUNS) | 2025-12-31 | $7.40M | +264.3% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $91.85M | -15.0% |
| Skinvisible, Inc. (SKVI) | 2025-12-31 | $10.39M | +10.8% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $20.33M | +127.9% |
| Altimmune, Inc. (ALT) | 2025-12-31 | $55.04M | +248.4% |
| Bioadaptives, Inc. (BDPT) | 2025-12-31 | $2.36M | +36.5% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $2.71M | +0.3% |
Compare TLPH, IBO, JUNS, LYEL side by side · Screen every company in Pharmaceutical Preparations ↗